Work

Potent Synergy between Combination of Chimeric Antigen Receptor (CAR) Therapy Targeting CD19 in Conjunction with Dendritic Cell (DC)/Tumor Fusion Vaccine in Hematological Malignancies

Year: 2019

Type: conference-abstract

Source: Blood

DOI: 10.1182/blood-2019-124944

Authors: Marzia Capelletti, Jessica Liegel, Maria Themeli, Tuna Mutis, Dina Stroopinsky, Shira Orr, Daniela Torres, Adam Morin, Gertrude Gunset, Haider Ghiasuddin, Maryam Rahimian, Myrna Nahas, Lina Bisharat, Shufen Meng, Nikhil C. Munshi, Donald Kufe, Jacalyn Rosenblatt, Michel Sadelain, David E. Avigan

Institutions: Beth Israel Deaconess Medical Center, Harvard University, Amsterdam University Medical Centers, Cancer Center Amsterdam, Amsterdam UMC Location Vrije Universiteit Amsterdam, University Medical Center Utrecht, Memorial Sloan Kettering Cancer Center, Dana-Farber Cancer Institute

Language: English

Topic: CAR-T cell therapy research

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2985749363

Cites:

Cited by: 2

Related to: 10